Detection of protein tyrosine-kinase (PTK) gene expression pattern in normal and malignant T lymphocytes by combined PTK-specific polymerase chain reaction and parallel denaturing gradient gel electrophoresis

Journal of Molecular Diagnostics

Volumn 5, Issue 2, 2003, Pages 113-120

  Wang, Zhi Yong ^a   Zhang, Qian ^a   Wilson, John ^a   Ratajczak, Mariusz Z ^a   Wasik, Mariusz A ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DNA FRAGMENT; MESSENGER RNA; PROTEIN TYROSINE KINASE; SOMATOMEDIN C RECEPTOR;

ARTICLE; CANCER CELL; CARCINOGENESIS; CELL ACTIVATION; CELL FUNCTION; CELL POPULATION; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA ISOLATION; ENZYME ACTIVE SITE; ENZYME INHIBITION; ENZYME SPECIFICITY; GEL ELECTROPHORESIS; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; LYMPHOPROLIFERATIVE DISEASE; MALIGNANT TRANSFORMATION; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN TARGETING; T LYMPHOCYTE;

EID: 0038365301     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-1578(10)60460-6     Document Type: Article

References (33)

1. Dong C, Davis RJ, Flavell RA: MAP kinases in the immune response. Annu Rev Immunol 2002, 20:55-72
2. Scheijen B, Griffin JD: Tyrosine kinase oncogenes in normal hematopoiesis and hematological disease. Oncogene 2002, 21:3314-3333
3. Frame MC, Fincham VJ, Carragher NO, Wyke JA: v-Src's hold over actin and cell adhesions. Nat Rev Mol Cell Bio 2002, 3:233-245
4. Skorski T: Oncogenic tyrosine kinases and the DNA-damage response. Nat Rev Cancer 2002, 2:351-360
5. Bridges AJ: Chemical inhibitors of protein kinases. Chemical Rev 2001, 101:2541-2572
6. Hao D, Rowinsky EK: Inhibiting signal transduction: recent advances in the development of receptor tyrosine kinase and Ras inhibitors. Cancer Invest 2002, 20:387-404
7. Savage DG, Antman KH: Imatinib mesylate-a new oral targeted therapy. N Engl J Med 2002, 346:683-693
8. Wilks AF: Two putative protein-tyrosine kinases identified by application of the polymerase chain reaction. Proc Natl Acad Sci USA 1989, 86:1603-1607
9. Matthews W, Jordan CT, Gavin M, Jenkins NA, Copeland NG, Lemischka IR: A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc Natl Acad Sci USA 1991, 88:9026-9030
10. Biesecker LG, Gottschalk LR, Emerson SG: Identification of four murine cDNAs encoding putative protein kinases from primitive embryonic stem cells differentiated in vitro. Proc Natl Acad Sci USA 1993, 90:7044-7048
11. Baserga R: The contradictions of the insulin-like growth factor 1 receptor. Oncogene 2000, 19:5574-5581
12. Valentinis B, Baserga R: IGF-I receptor signaling in transformation and differentiation. Mol Pathol 2001, 54:133-137
13. Zhang Q, Raghunath PN, Vonderheid E, Ødum N, Wasik MA: Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter. Am J Pathol 2000, 157:1137-1146
14. Majewski M, Korecka M, Kossev P, Li S, Goldman J, Moore J, Silberstein L, Nowell PC, Schuler W, Shaw L, Wasik MA: Immunosuppressive macrolide SDZ RAD inhibits growth of human EBV-transformed B lymphocytes in vitro and in vivo; a potential approach to prevention and treatment of posttransplant lymphoproliferative disorders (PTLDs). Proc Natl Acad Sci USA 2000, 97:4285-4290
15. Abrams JT, Lessin S, Ghosh SK, Ju W, Vonderheid EC, Nowell P, Murphy G, Elfenbein B, DeFreitas E: A clonal CD4-positive T-cell line established from the blood of a patient with Sezary syndrome. J Invest Dermatol 1991, 96:31-37
16. Yodoi J, Teshigawara K: TCGF (IL-2)-receptor inducing factor(s). I Regulation of IL-2 receptor on a natural killer-like cell line (YT cells) J Immunol 1985, 134:1623-1630
17. Zhang Q, Raghunath PN, Xue L, Majewski M, Carpentieri DF, Odum N, Morris S, Skorski T, Wasik MA: Multilevel dysregulation of STAT3 activation in ALK+ T/null-cell lymphoma. J Immunol 2002, 168:466-474
18. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159
19. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local alignment search tool. J Mol Biol 1990, 215:403-410
20. Ratajczak J, Zhang Q, Pertusini E, Wojczyk B, Wasik MA, Ratajczak M: The role of insulin (INS) and insulin-like growth factor-I (IGF-I) in regulation of human erythropoiesis. Studies in vitro under serum-free conditions; comparison to other cytokines and growth factors. Leukemia 1998, 12:371-381
21. Gescher A: Staurosporine analogues - pharmacological toys or useful antitumour agents? Crit Rev Oncol Hematol 2000, 34:127-135
22. Chevillard S, Radicella JP, Levalois C, Lebeau J, Poupon MF, Oudard S, Dutrillaux B, Boiteux S: Mutations in OGG1, a gene involved in the repair of oxidative DNA damage, are found in human lung and kidney tumours. Oncogene 1998, 16:3083-3086
23. Antoniadi T, Gronskov K, Sand A, Pampanos A, Brondum-Nielsen K, Petersen MB: Mutation analysis of the GJB2 (connexin 26) gene by DGGE in Greek patients with sensorineural deafness. Human Mutation 2000, 16:7-12
24. Wood GS, Tung RM, Haeffner AC, Crooks CF, Liao S, Orozco R, Veelken H, Kadin ME, Koh H, Heald P: Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/ Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE). J Invest Dermatol 1994, 103: 34-44
25. Theodoro I, Delfau-Larue MH, Bigorgne C, Lahet C, Cochet G, Bagot M, Wechsler J, Farcet JP: Cutaneous T-cell infiltrates: analysis of T-cell receptor γ gene rearrangement by polymerase chain reaction and denaturating gradient gel electrophoresis. Blood 1995, 86:305-310
26. Liu K, Kao KJ: Measurement of relative quantities of different HLA-A and -B mRNAs in cells by reverse transcription-polymerase chain reaction and denaturing gradient gel electrophoresis. J Immunol Methods 1997, 203:67-75
27. Saito K, Nishikawa J, Imagawa M, Nishihara T, Matsuo M: Molecular evidence of complex tissue- and sex-specific mRNA expression of the rat α(2u)-globulin multigene family. Biochem Biophys Res Commun 2000, 272:337-344
28. Lisitsyn N, Wigler M: Representational difference analysis in detection of genetic lesions in cancer. Methods Enzymol 1995, 254:291-304
29. Staudt LM: Gene expression profiling of lymphoid malignancies. Annu Rev Med 2002, 53:303-318
30. Ramaswamy S, Golub TR: DNA microarrays in clinical oncology. J Clin Oncol 2002, 20:1932-1941
31. Pollack JR, Van de Rijn M, Botstein D: Challenges in developing a molecular characterization of cancer. Semin Oncol 2002, 29:280-285
32. Shipp MA, Ross KN, Tamayo P, Wang AP, Kutok JL, Aguiar RC, Gaasenbeek M, Angelo M, Reich M, Pinkus GS, Ray TS, Koval MA, Last KW, Norton A, Lister TA, Mesirov J, Neuberg DS, Lander ES, Aster JC, Golub TR: Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med 2002, 8:68-74
33. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, Hurt EM, Zhao H, Averett L, Yang L, Wilson WH, Jaffe ES, Simon R, Klausner RD, Powell J, Duffey PL, Longo DL, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ, Lynch JC, Vose J, Armitage JO, Montserrat E, Lopez-Guillermo A, Grogan TM, Miller TP, LeBlanc M, Ott G, Kvaloy S, Delabie J, Holte H, Krajci P, Stokke T, Staudt LM: Lymphoma/Leukemia Molecular Profiling Project. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002, 346:1937-1947